BG102716A - Method for the treatment of cardiac insufficiency by means of formulations opposing the endotheline - Google Patents

Method for the treatment of cardiac insufficiency by means of formulations opposing the endotheline

Info

Publication number: BG102716A
Authority: BG; Bulgaria
Prior art keywords: treatment; endotheline; formulations; opposing; cardiac insufficiency
Prior art date: 1996-04-04

Application number

BG102716A

Other languages

Bulgarian (bg)

English (en)

Inventor

Joseph Lynch

You-Tang Shen

Original Assignee

Joseph Lynch

You-Tang Shen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-04-04

Filing date

1998-08-21

Publication date

1999-09-30

1998-08-21 Application filed by Joseph Lynch, You-Tang Shen filed Critical Joseph Lynch

1999-09-30 Publication of BG102716A publication Critical patent/BG102716A/xx

Links

206010019280 Heart failures Diseases 0.000 title 1
238000009472 formulation Methods 0.000 title 1
238000000034 method Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Materials For Photolithography (AREA)
Photosensitive Polymer And Photoresist Processing (AREA)

BG102716A 1996-04-04 1998-08-21 Method for the treatment of cardiac insufficiency by means of formulations opposing the endotheline BG102716A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1488296P	1996-04-04	1996-04-04
PCT/US1997/003737 WO1997037665A1 (en)	1996-04-04	1997-03-19	Method of treating heart failure with endothelin antagonists

Publications (1)

Publication Number	Publication Date
BG102716A true BG102716A (en)	1999-09-30

Family

ID=21768326

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG102716A BG102716A (en)	1996-04-04	1998-08-21	Method for the treatment of cardiac insufficiency by means of formulations opposing the endotheline

Country Status (25)

Country	Link
US (3)	US5834483A (de)
EP (1)	EP0906108B1 (de)
JP (2)	JP3345891B2 (de)
KR (1)	KR20000005178A (de)
CN (1)	CN1215335A (de)
AT (1)	ATE297739T1 (de)
AU (1)	AU723351B2 (de)
BG (1)	BG102716A (de)
BR (1)	BR9708525A (de)
CA (1)	CA2249330C (de)
CZ (1)	CZ296098A3 (de)
DE (1)	DE69733557T2 (de)
EA (1)	EA003587B1 (de)
EE (1)	EE9800315A (de)
ES (1)	ES2241047T3 (de)
HU (1)	HUP9903893A3 (de)
IL (1)	IL126175A (de)
IS (1)	IS4847A (de)
NO (1)	NO984564L (de)
NZ (1)	NZ331789A (de)
PL (1)	PL329077A1 (de)
SK (1)	SK130098A3 (de)
TR (1)	TR199801988T2 (de)
UA (1)	UA50761C2 (de)
WO (1)	WO1997037665A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EE9800315A (et)	1996-04-04	1999-06-15	Banyu Pharmaceutical Co., Ltd.	Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil
AU711936B2 (en) *	1996-08-09	1999-10-28	Banyu Pharmaceutical Co., Ltd.	Stereoselective deoxygenation reaction
US6413979B1 (en)	1998-01-21	2002-07-02	Banyu Pharmaceutical Co., Ltd.	Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative
US8168616B1 (en)	2000-11-17	2012-05-01	Novartis Ag	Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
AU2003289020A1 (en) *	2002-12-27	2004-07-29	Kaneka Corporation	Processes for producing optically active 2-thiomethyl-3-phenylpropionic acid derivative and for producing intermediate therefor
JP2007511487A (ja)	2003-11-17	2007-05-10	ノバルティスアクチエンゲゼルシャフト	ジペプチジルペプチダーゼｉｖ阻害剤の使用
GB0327839D0 (en)	2003-12-01	2003-12-31	Novartis Ag	Organic compounds
RU2426532C2 (ru)	2004-03-17	2011-08-20	Новартис Аг	Применение органических соединений
WO2006137222A1 (ja)	2005-06-24	2006-12-28	Tokyo Medical And Dental University	薬剤溶出速度制御方法、及び薬剤溶出性ステント被膜用組成物
WO2011116115A1 (en)	2010-03-16	2011-09-22	Novartis Ag	Aliskiren composition comprising a medium chain fatty acid, their process of manufacturing

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4971959A (en) *	1987-04-14	1990-11-20	Warner-Lambert Company	Trisubstituted phenyl analogs having activity for congestive heart failure
GB9007762D0 (en) *	1990-04-05	1990-06-06	Beecham Group Plc	Novel compounds
US5565485A (en) *	1993-03-19	1996-10-15	Merck & Co., Inc.	Biphenyl compounds useful or endothelin antagonists
DK0699069T3 (da)	1993-04-27	2002-05-27	Smithkline Beecham Corp	Endothelinreceptorantagonister
US5571813A (en) *	1993-06-10	1996-11-05	Beiersdorf-Lilly Gmbh	Fused pyrimidine compounds and their use as pharmaceuticals
DK0714897T3 (da) *	1993-08-18	2001-03-19	Banyu Pharma Co Ltd	Ring-kondenseret heteroaromatisk cyclopentenderivat med endothelinantagonist-aktivitet
US5389620A (en) *	1993-08-18	1995-02-14	Banyu Pharmaceutical Co., Ltd.	Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
US5658943A (en) *	1995-01-05	1997-08-19	Warner-Lambert Company	Phenylalanine derivatives as endothelin antagonists
EE9800315A (et) *	1996-04-04	1999-06-15	Banyu Pharmaceutical Co., Ltd.	Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil

1997
- 1997-03-19 EE EE9800315A patent/EE9800315A/xx unknown
- 1997-03-19 JP JP53619497A patent/JP3345891B2/ja not_active Expired - Fee Related
- 1997-03-19 CA CA002249330A patent/CA2249330C/en not_active Expired - Fee Related
- 1997-03-19 SK SK1300-98A patent/SK130098A3/sk unknown
- 1997-03-19 WO PCT/US1997/003737 patent/WO1997037665A1/en not_active Ceased
- 1997-03-19 DE DE69733557T patent/DE69733557T2/de not_active Expired - Lifetime
- 1997-03-19 IL IL12617597A patent/IL126175A/xx not_active IP Right Cessation
- 1997-03-19 UA UA98105222A patent/UA50761C2/uk unknown
- 1997-03-19 CN CN97193645A patent/CN1215335A/zh active Pending
- 1997-03-19 KR KR1019980707850A patent/KR20000005178A/ko not_active Ceased
- 1997-03-19 AT AT97914955T patent/ATE297739T1/de not_active IP Right Cessation
- 1997-03-19 BR BR9708525A patent/BR9708525A/pt not_active Application Discontinuation
- 1997-03-19 TR TR1998/01988T patent/TR199801988T2/xx unknown
- 1997-03-19 HU HU9903893A patent/HUP9903893A3/hu unknown
- 1997-03-19 PL PL97329077A patent/PL329077A1/xx unknown
- 1997-03-19 ES ES97914955T patent/ES2241047T3/es not_active Expired - Lifetime
- 1997-03-19 EP EP97914955A patent/EP0906108B1/de not_active Expired - Lifetime
- 1997-03-19 CZ CZ982960A patent/CZ296098A3/cs unknown
- 1997-03-19 NZ NZ331789A patent/NZ331789A/xx unknown
- 1997-03-19 AU AU22025/97A patent/AU723351B2/en not_active Ceased
- 1997-03-19 EA EA199800889A patent/EA003587B1/ru not_active IP Right Cessation
- 1997-03-26 US US08/824,848 patent/US5834483A/en not_active Expired - Fee Related
1998
- 1998-08-11 US US09/132,514 patent/US6087360A/en not_active Expired - Lifetime
- 1998-08-21 BG BG102716A patent/BG102716A/xx unknown
- 1998-09-15 IS IS4847A patent/IS4847A/is unknown
- 1998-09-30 NO NO984564A patent/NO984564L/no not_active Application Discontinuation
2000
- 2000-02-22 US US09/507,666 patent/US6380195B1/en not_active Expired - Fee Related
2001
- 2001-12-07 JP JP2001374870A patent/JP2002220337A/ja active Pending

Also Published As

Publication number	Publication date
PL329077A1 (en)	1999-03-15
JP2002220337A (ja)	2002-08-09
AU2202597A (en)	1997-10-29
EP0906108A1 (de)	1999-04-07
US5834483A (en)	1998-11-10
HUP9903893A2 (hu)	2001-04-28
NO984564L (no)	1998-12-04
CA2249330C (en)	2005-08-09
NZ331789A (en)	2000-05-26
KR20000005178A (ko)	2000-01-25
JP3345891B2 (ja)	2002-11-18
IL126175A (en)	2003-05-29
EP0906108A4 (de)	2000-12-06
AU723351B2 (en)	2000-08-24
JP2000510824A (ja)	2000-08-22
DE69733557T2 (de)	2005-11-03
ATE297739T1 (de)	2005-07-15
NO984564D0 (no)	1998-09-30
ES2241047T3 (es)	2005-10-16
CN1215335A (zh)	1999-04-28
US6380195B1 (en)	2002-04-30
EE9800315A (et)	1999-06-15
DE69733557D1 (de)	2005-07-21
UA50761C2 (uk)	2002-11-15
BR9708525A (pt)	1999-08-03
WO1997037665A1 (en)	1997-10-16
EA003587B1 (ru)	2003-06-26
IS4847A (is)	1998-09-15
CA2249330A1 (en)	1997-10-16
EA199800889A1 (ru)	1999-04-29
IL126175A0 (en)	1999-05-09
US6087360A (en)	2000-07-11
SK130098A3 (en)	1999-05-07
HUP9903893A3 (en)	2001-05-28
CZ296098A3 (cs)	1999-06-16
EP0906108B1 (de)	2005-06-15
TR199801988T2 (xx)	2000-08-21

Publication	Publication Date	Title
UA26213C2 (uk)	1999-07-19	Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
UA39158C2 (uk)	2001-06-15	Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
YU28199A (sh)	2002-03-18	Novi oblik jedinjenja
IL110943A0 (en)	1994-11-28	Compositions for the treatment of skin disorders
IL121170A0 (en)	1997-11-20	Compositions for the treatment of dermatological disorders
HUP9903166A3 (en)	2003-09-29	Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
FI941826A7 (fi)	1994-10-22	Menetelmät ja koostumukset elimen hypofunktion ennaltaehkäisemiseksi ja/tai terapeuttiseksi hoitamiseksi
ZA943744B (en)	1995-04-26	Therapeutic substituted guanidines
AU2160492A (en)	1993-01-12	Treatment of human diseases involving dysregulation or dysfunction of the nervous system
GB8900678D0 (en)	1989-03-08	Compositions for the prevention and medical treatment of parodonthopathy
UA41355C2 (uk)	2001-09-17	Засіб для лікування нейро-сніду
BG102818A (en)	1999-05-31	D-manitol and method for its preparation
GB2311940B (en)	2000-07-19	Pharmaceutical compositions for the treatment of rhinitis
ZA977310B (en)	1998-03-27	Transdermal propentofylline compositions for the treatment of Alzheimer's disease.
MXPA94009086A (es)	2006-02-14	Guanidinas sustituidas terapeuticas.
IN167848B (de)	1990-12-29
BG102667A (en)	1999-02-26	Diosgenine-containing composition
IL111805A0 (en)	1995-01-24	Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
UA50761C2 (uk)	2002-11-15	Спосіб запобігання та/або лікування серцевих захворювань, фармацевтична композиція та спосіб запобігання та/або лікування серцевої недостатності та дисфункції шлуночків в організмі теплокровної тварини
GR76280B (de)	1984-08-04
IL113057A0 (en)	1995-06-29	Compositions for the treatment of dandruff
DE59104412D1 (de)	1995-03-09	Dynamische Redressionsschiene zur Therapie der Vorfussadduktion.
GB9510162D0 (en)	1995-07-12	Compositions for the treatment of skin conditions
ZA949564B (en)	1995-08-16	Method for treating constipation using dimeticone.
IL124576A0 (en)	1999-01-26	Compositions and methods for the prevention and treatment of oral mucositis